{"filing":{"accession_number":"0000950103-26-016060","cik":"0001015820","ticker":"QGEN","company_name":"QIAGEN N.V.","form":"6-K","filing_date":"2026-10-23","report_date":"2026-10-23","primary_document":"dp255417_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1015820/000095010326016060/dp255417_6k.htm"},"events":[{"id":37400,"run_id":34475,"accession_number":"0000950103-26-016060","anchor_item_number":"EX-99.3","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"This exhibit is the executed Business Combination Agreement dated 21 October 2026 between Crown NL Bidco B.V. (Buyer) and QIAGEN N.V. (Company) for a full public tender offer to acquire all issued ordinary shares of QIAGEN at EUR 46.50 per share. The agreement documents entry into a material acquisition transaction involving a change of control, with detailed provisions for the offer mechanics, financing, regulatory approvals, and post-closing restructuring including delisting and squeeze-out proceedings. This is a classic M\u0026A activity disclosure under Item 1.01 of an 8-K equivalent.","company_name":"QIAGEN N.V.","ticker":"QGEN","filing_date":"2026-10-23","form":"6-K","submitted_at":null,"items":[{"id":42101,"accession_number":"0000950103-26-016060","item_number":"EX-99.3","item_title":"dp255417_ex9903.htm","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"This exhibit is the executed Business Combination Agreement dated 21 October 2026 between Crown NL Bidco B.V. (Buyer) and QIAGEN N.V. (Company) for a full public tender offer to acquire all issued ordinary shares of QIAGEN at EUR 46.50 per share. The agreement documents entry into a material acquisition transaction involving a change of control, with detailed provisions for the offer mechanics, financing, regulatory approvals, and post-closing restructuring including delisting and squeeze-out proceedings. This is a classic M\u0026A activity disclosure under Item 1.01 of an 8-K equivalent.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-23T10:12:38.463218+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":42101,"accession_number":"0000950103-26-016060","item_number":"EX-99.3","item_title":"dp255417_ex9903.htm","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"This exhibit is the executed Business Combination Agreement dated 21 October 2026 between Crown NL Bidco B.V. (Buyer) and QIAGEN N.V. (Company) for a full public tender offer to acquire all issued ordinary shares of QIAGEN at EUR 46.50 per share. The agreement documents entry into a material acquisition transaction involving a change of control, with detailed provisions for the offer mechanics, financing, regulatory approvals, and post-closing restructuring including delisting and squeeze-out proceedings. This is a classic M\u0026A activity disclosure under Item 1.01 of an 8-K equivalent.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-23T10:12:38.463218+00:00","company_name":"QIAGEN N.V.","ticker":"QGEN","filing_date":"2026-10-23"}]}